APA (7th ed.) Citation

Park SI, Lee H, Oh J, Lim KS, Jang IJ, Kim JA, . . . Yu KS. (2015). A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects. Dove Medical Press.

Chicago Style (17th ed.) Citation

Park SI, Lee H, Oh J, Lim KS, Jang IJ, Kim JA, Jung JH, and Yu KS. A Fixed-dose Combination Tablet of Gemigliptin and Metformin Sustained Release Has Comparable Pharmacodynamic, Pharmacokinetic, and Tolerability Profiles to Separate Tablets in Healthy Subjects. Dove Medical Press, 2015.

MLA (9th ed.) Citation

Park SI, et al. A Fixed-dose Combination Tablet of Gemigliptin and Metformin Sustained Release Has Comparable Pharmacodynamic, Pharmacokinetic, and Tolerability Profiles to Separate Tablets in Healthy Subjects. Dove Medical Press, 2015.